AI in Drug Discovery Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-09-23　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 3,240.0 Mn
2033 年預估規模: USD 15,536.2 Mn
年複合成長率 CAGR: 25.1%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

完整報告名稱與涵蓋範圍

AI in Drug Discovery Market, By Offering (Software, Services), By Technology (Machine Learning, Deep Learning, Generative AI, Natural Language Processing, Others), By Drug Discovery Process (Target Identification and Validation, Hit Identification and Screening, Lead Identification and Optimization, Preclinical Development), By Drug Type (Small-Molecule Drugs, Large-Molecule Drugs), By Application (Drug Repurposing, De Novo Drug Design, Virtual Screening, Biomarker Discovery, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic and Research Institutes, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global AI in drug discovery market is estimated to be valued at USD 3,240.0 Mn in 2026 and is expected to reach USD 15,536.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 25.1% from 2026 to 2033. Artificial intelligence (AI) is revolutionizing drug discovery in pharmaceutical research by accelerating the identification, development and optimization of novel therapeutic compounds. Researchers are using machine learning, deep learning, natural language processing, and generative AI techniques to analyze complex biological data, predict molecular interactions, identify drug targets, and improve virtual screening and lead optimization. AI leverages genomic, protein, biomarker and clinical data to generate multidimensional insights that may improve the efficiency and accuracy of drug discovery. The increasing adoption of AI-driven platforms by pharmaceutical companies, biotech firms and research institutes is leading to the creation of more efficient discovery workflows and fueling the expansion of the Global AI in Drug Discovery Market. Market Dynamics The global AI in drug discovery market is driven by the escalating cost and complexity of traditional drug discovery, increasing pharmaceutical R&D expenditure, and the mounting volume of genomic, proteomic, and chemical data. AI is accelerating processes such as target identification, virtual screening, lead optimization, and drug property prediction. Furthermore, the increasing collaborations between technology and pharmaceutical companies are fueling the adoption of AI across the drug discovery process. However, a number of constraints are present in the market, such as standardization issues, data privacy and intellectual property concerns, regulatory uncertainty, and a shortage of professionals with combined AI and life sciences expertise. Nevertheless, significant opportunities exist in generative AI for de novo molecule design, AI-enabled development of therapies for rare diseases, and growing adoption in emerging markets such as Asia-Pacific and Latin America. Key Features of the Study • This report provides in-depth analysis of the global AI in drug discovery market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global AI in drug discovery market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Schrödinger, Inc., Insilico Medicine, Recursion Pharmaceuticals, Inc., Isomorphic Labs Limited, XtalPi Inc., insitro, Inc., BenevolentAI, Generate Biomedicines, Inc., Owkin, Inc., and Atomwise, Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global AI in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global AI in drug discovery market Market Segmentation • Offering Insights (Revenue, USD Mn, 2021 - 2033) o Software o Services • Technology Insights (Revenue, USD Mn, 2021 - 2033) o Machine Learning o Deep Learning o Generative AI o Natural Language Processing o Others • Drug Discovery Process Insights (Revenue, USD Mn, 2021 - 2033) o Target Identification and Validation o Hit Identification and Screening o Lead Identification and Optimization o Preclinical Development • Drug Type Insights (Revenue, USD Mn, 2021 - 2033) o Small-Molecule Drugs o Large-Molecule Drugs • Application Insights (Revenue, USD Mn, 2021 - 2033) o Drug Repurposing o De Novo Drug Design o Virtual Screening o Biomarker Discovery o Others • End User Insights (Revenue, USD Mn, 2021 - 2033) o Pharmaceutical and Biotechnology Companies o Contract Research Organizations (CROs) o Academic and Research Institutes o Others • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Schrödinger, Inc. o Insilico Medicine o Recursion Pharmaceuticals, Inc. o Isomorphic Labs Limited o XtalPi Inc. o insitro, Inc. o BenevolentAI o Generate Biomedicines, Inc. o Owkin, Inc. o Atomwise, Inc.

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global AI in Drug Discovery Market, By Offering  Global AI in Drug Discovery Market, By Technology  Global AI in Drug Discovery Market, By Drug Discovery Process  Global AI in Drug Discovery Market, By Drug Type  Global AI in Drug Discovery Market, By Application  Global AI in Drug Discovery Market, By End User  Global AI in Drug Discovery Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Offering Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Industry Trends 4. Global AI in Drug Discovery Market, By Offering, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Software  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Services  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global AI in Drug Discovery Market, By Technology, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Machine Learning  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Deep Learning  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Generative AI  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Natural Language Processing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global AI in Drug Discovery Market, By Drug Discovery Process, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Target Identification and Validation  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hit Identification and Screening  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Lead Identification and Optimization  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Preclinical Development  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global AI in Drug Discovery Market, By Drug Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Small-Molecule Drugs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Large-Molecule Drugs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global AI in Drug Discovery Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Drug Repurposing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o De Novo Drug Design  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Virtual Screening  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Biomarker Discovery  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global AI in Drug Discovery Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Pharmaceutical and Biotechnology Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Contract Research Organizations (CROs)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Academic and Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Global AI in Drug Discovery Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Offering, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Discovery Process, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Schrödinger, Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o Insilico Medicine  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o Recursion Pharmaceuticals, Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o Isomorphic Labs Limited  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o XtalPi Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o insitro, Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o BenevolentAI  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o Generate Biomedicines, Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o Owkin, Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies o Atomwise, Inc.  Company Highlights  Offering Portfolio  Key Developments  Financial Performance  Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘AI in Drug Discovery Market' - Global forecast to 2033

提及公司

Schrödinger, Inc.Insilico MedicineRecursion Pharmaceuticals, Inc.Isomorphic Labs LimitedXtalPi Inc.insitro, Inc.BenevolentAIGenerate Biomedicines, Inc.Owkin, Inc.Atomwise, Inc.

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們